Testing effectiveness (Phase 2)Study completedNCT05444998What this trial is testingNeoadjuvant Inetetamab and Pyrotinib and Nab-paclitaxel for HER2+Breast CancerWho this might be right forBreast Cancer Xijing Hospital 20
Not applicableLooking for participantsNCT06630793What this trial is testingIMRT Versus IMPT With Concurrent Chemotherapy for Locally Advanced Anal Canal CancerWho this might be right forMalignant Neoplasm of Anal Canal Tata Memorial Centre 108
Early research (Phase 1)UnknownNCT05768321What this trial is testingStudy of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C MutationWho this might be right forAdvanced Solid Tumors GenEros Biopharma Hangzhou Ltd 70
Testing effectiveness (Phase 2)Ended earlyNCT01101906What this trial is testingA Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCCWho this might be right forAdvanced Hepatocellular Carcinoma (HCC) Astellas Pharma Inc 23
Testing effectiveness (Phase 2)Study completedNCT01294306What this trial is testingMK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride TherapyWho this might be right forAdenosquamous Lung CarcinomaBronchioloalveolar CarcinomaLarge Cell Lung Carcinoma+3 more National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT05564806What this trial is testingStudy of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin LymphomaWho this might be right forAdvanced Solid TumorsRelapsed Or Refractory Non-Hodgkin Lymphoma Eucure (Beijing) Biopharma Co., Ltd 9
Not applicableStudy completedNCT02884947What this trial is testingImproving Surgical Outcomes in Patients With Low Grade Gliomas Using Advanced Pre- and Intra-operative MRIWho this might be right forBrain Neoplasms University College, London 31
Testing effectiveness (Phase 2)Looking for participantsNCT06441747What this trial is testingPhase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)Who this might be right forCholangiocarcinoma Australasian Gastro-Intestinal Trials Group 40
Very early researchStudy completedNCT05678348What this trial is testingPyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck CancerCancer of the Head and Neck Washington University School of Medicine 22
Testing effectiveness (Phase 2)Study completedNCT03759600What this trial is testingJapan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian CancerWho this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Cancer Takeda 20
Early research (Phase 1)Looking for participantsNCT07156136What this trial is testingStudy of IMC-P115C in Advanced PRAME-Positive CancersWho this might be right forPRAME PositiveCancerHLA-A*02:01-positive Immunocore Ltd 140
Testing effectiveness (Phase 2)UnknownNCT05754736What this trial is testingClinical Study of Ametinib Combined With Bevacizumab in First-line Treatment of Advanced NSCLC With EGFR-mutations.Who this might be right forNon-small Cell Lung Cancer The Second Affiliated Hospital of Shandong First Medical University 50
Testing effectiveness (Phase 2)Ended earlyNCT02451111What this trial is testingRituximab With or Without Ibrutinib for Patients With Advanced Follicular LymphomaWho this might be right forFollicular Lymphoma Swiss Cancer Institute 190
Testing effectiveness (Phase 2)Looking for participantsNCT06742411What this trial is testingXELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJCWho this might be right forGastric (Stomach) Cancer West China Hospital 57
Large-scale testing (Phase 3)Active Not RecruitingNCT02460887What this trial is testingThe Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRTWho this might be right forNasopharyngeal Carcinoma Sun Yat-sen University 236
Early research (Phase 1)Study completedNCT03667716What this trial is testingCOM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.Who this might be right forAdvanced CancerOvarian CancerBreast Cancer+7 more Compugen Ltd 121
Testing effectiveness (Phase 2)Ended earlyNCT00022633What this trial is testingS0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer SWOG Cancer Research Network 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT03653052What this trial is testingDo Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving DurvalumabWho this might be right forOesophageal Cancer Simon C Pacey, MD 18
Not applicableActive Not RecruitingNCT06059300What this trial is testingDigital Breast Tomosynthesis for the Dutch National Breast Cancer Screening ProgramWho this might be right forBreast Cancer Screening Radboud University Medical Center 18,200
Testing effectiveness (Phase 2)Study completedNCT03110744What this trial is testingCDK4/6 Inhibition in Locally Advanced/Metastatic ChordomaWho this might be right forChordoma University Hospital Heidelberg 43